Metabolic activity of excitatory parafascicular and pedunculopontine inputs to the subthalamic nucleus in a rat model of Parkinson's disease

[1]  E. Hirsch,et al.  Plasticity of nerve afferents to nigrostriatal neurons in parkinson's disease , 1995, Annals of neurology.

[2]  Y Agid,et al.  Systemic Administration of NMDA and AMPA Receptor Antagonists Reverses the Neurochemical Changes Induced by Nigrostriatal Denervation in Basal Ganglia , 1999, Journal of neurochemistry.

[3]  J. Deniau,et al.  Prefrontal cortex‐basal ganglia circuits in the rat: Involvement of ventral pallidum and subthalamic nucleus , 1998, Synapse.

[4]  M. Deschenes,et al.  A Single‐cell Study of the Axonal Projections Arising from the Posterior Intralaminar Thalamic Nuclei in the Rat , 1996, The European journal of neuroscience.

[5]  A. Benabid,et al.  Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation , 1995, The Lancet.

[6]  Larry L. Butcher,et al.  Cholinergic systems in the rat brain: III. Projections from the pontomesencephalic tegmentum to the thalamus, tectum, basal ganglia, and basal forebrain , 1986, Brain Research Bulletin.

[7]  R. Spencer,et al.  A cholinergic projection to the rat substantia nigra from the pedunculopontine tegmental nucleus , 1987, Brain Research.

[8]  S. T. Kitai,et al.  Two types of cholinergic neurons in the rat tegmental pedunculopontine nucleus: electrophysiological and morphological characterization , 1997, Neuroscience.

[9]  J. Bolam,et al.  The glutamate‐enriched cortical and thalamic input to neurons in the subthalamic nucleus of the rat: Convergence with GABA‐positive terminals , 1995, The Journal of comparative neurology.

[10]  Y. Smith,et al.  The subthalamic nucleus and the external pallidum: two tightly interconnected structures that control the output of the basal ganglia in the monkey , 1996, Neuroscience.

[11]  J A Obeso,et al.  Consequences of Nigrostriatal Denervation on the Functioning of the Basal Ganglia in Human and Nonhuman Primates: An In Situ Hybridization Study of Cytochrome Oxidase Subunit I mRNA , 1997, The Journal of Neuroscience.

[12]  M. Wong-Riley,et al.  Neuronal expression of nuclear and mitochondrial genes for cytochrome oxidase (CO) subunits analyzed by in situ hybridization: comparison with CO activity and protein , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[13]  M. Chesselet,et al.  Effects of nigrostriatal lesions on the levels of messenger RNAs encoding two isoforms of glutamate decarboxylase in the globus pallidus and entopeduncular nucleus of the rat , 1992, Synapse.

[14]  J. Deniau,et al.  Relationships between the Prefrontal Cortex and the Basal Ganglia in the Rat: Physiology of the Corticosubthalamic Circuits , 1998, The Journal of Neuroscience.

[15]  E. Hirsch,et al.  Subthalamotomy in parkinsonian monkeys. Behavioural and biochemical analysis. , 1996, Brain : a journal of neurology.

[16]  B. K. Hartman,et al.  Glutamate-enriched cholinergic synaptic terminals in the entopeduncular nucleus and subthalamic nucleus of the rat , 1997, Neuroscience.

[17]  L. Tremblay,et al.  Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism , 1991, Brain Research.

[18]  B Bioulac,et al.  Reversal of Rigidity and Improvement in Motor Performance by Subthalamic High‐frequency Stimulation in MPTP‐treated Monkeys , 1993, The European journal of neuroscience.

[19]  F. Blandini,et al.  Subthalamic Ablation Reverses Changes in Basal Ganglia Oxidative Metabolism and Motor Response to Apomorphine Induced by Nigrostriatal Lesion in Rats , 1997, The European journal of neuroscience.

[20]  M. Wong-Riley,et al.  Mitochondrial and nuclear gene expression for cytochrome oxidase subunits are disproportionately regulated by functional activity in neurons , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[21]  J. Bolam,et al.  Cholinergic, GABAergic, and glutamate-enriched inputs from the mesopontine tegmentum to the subthalamic nucleus in the rat , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[22]  L. Naudon,et al.  Reserpine Affects Differentially the Density of the Vesicular Monoamine Transporter and Dihydrotetrabenazine Binding Sites , 1996, The European journal of neuroscience.

[23]  J. Walters,et al.  Unilateral lesion of the nigrostriatal pathway decreases the firing rate and alters the firing pattern of globus pallidus neurons in the rat , 1988, Synapse.

[24]  H. Bergman,et al.  The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. , 1994, Journal of neurophysiology.

[25]  Y. Smith,et al.  Topographical and Synaptic Organization of the GABA‐Containing Pallidosubthalamic Projection in the Rat , 1990, The European journal of neuroscience.

[26]  O. Hassani,et al.  Increased subthalamic neuronal activity after nigral dopaminergic lesion independent of disinhibition via the globus pallidus , 1996, Neuroscience.

[27]  T. Engber,et al.  NMDA receptor blockade reverses motor response alterations induced by levodopa. , 1994, Neuroreport.

[28]  J. Penney,et al.  The functional anatomy of basal ganglia disorders , 1989, Trends in Neurosciences.

[29]  T. Hattori,et al.  Direct projections from the centre median‐parafascicular complex to the subthalamic nucleus in the cat and rat , 1983, The Journal of comparative neurology.

[30]  A. Parent,et al.  Pedunculopontine nucleus in the squirrel monkey: Projections to the basal ganglia as revealed by anterograde tract‐tracing methods , 1994, The Journal of comparative neurology.

[31]  N. Canteras,et al.  Somatosensory inputs to the subthalamic nucleus: a combined retrograde and anterograde horseradish peroxidase study in the rat , 1988, Brain Research.

[32]  G. Skuza,et al.  Some central effects of CGP 37849 and CGP 39551, the competitive NMDA receptor antagonists: potential antiparkinsonian activity , 1993 .

[33]  M. Delong,et al.  Primate models of movement disorders of basal ganglia origin , 1990, Trends in Neurosciences.

[34]  R. Kurlan,et al.  Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease , 1994, Annals of neurology.

[35]  M. Roger,et al.  Afferents to the zona incerta in the rat: A combined retrograde and anterograde study , 1985, The Journal of comparative neurology.

[36]  M. Mouroux,et al.  Evidence that the parafascicular projection to the subthalamic nucleus is glutamatergic. , 1993, Neuroreport.

[37]  N. Canteras,et al.  Afferent connections of the subthalamic nucleus: a combined retrograde and anterograde horseradish peroxidase study in the rat , 1990, Brain Research.

[38]  George Maeda,et al.  Regional metabolic changes in the pedunculopontine nucleus of unilateral 6-hydroxydopamine Parkinson's model rats , 1999, Brain Research.

[39]  H. Bergman,et al.  Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. , 1990, Science.

[40]  J. Deniau,et al.  Cortical inputs to the subthalamus: intracellular analysis , 1981, Brain Research.

[41]  C. Gerfen.  The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. , 1992, Annual review of neuroscience.

[42]  J. Besson,et al.  Diencephalic connections of the raphé nuclei of the rat brainstem: An anatomical study with reference to the somatosensory system , 1984, The Journal of comparative neurology.

[43]  Y. Agid,et al.  Consequence of nigrostriatal denervation and L-dopa therapy on the expression of glutamic acid decarboxylase messenger RNA in the pallidum , 1996, Neurology.

[44]  C. Hammond,et al.  Anatomical and electrophysiological studies on the reciprocal projections between the subthalamic nucleus and nucleus tegmenti pedunculopontinus in the rat , 1983, Neuroscience.

[45]  O. Hassani,et al.  Evidence for a dopaminergic innervation of the subthalamic nucleus in the rat , 1997, Brain Research.

[46]  J. A. Obeso,et al.  Metabolic activity of the basal ganglia in parkinsonian syndromes in human and non-human primates: A cytochrome oxidase histochemistry study , 1996, Neuroscience.

[47]  O. Hassani,et al.  Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states , 1997, Neuroscience.

[48]  M. Starr,et al.  Stimulation of basal and l-DOPA-induced motor activity by glutamate antagonists in animal models of Parkinson's disease , 1997, Neuroscience & Biobehavioral Reviews.

[49]  M. Bevan,et al.  The projections from the parafascicular thalamic nucleus to the subthalamic nucleus and the striatum arise from separate neuronal populations: A comparison with the corticostriatal and corticosubthalamic efferents in a retrograde fluorescent double-labelling study , 1994, Neuroscience.

[50]  P. Kalivas,et al.  GABAergic projection from the ventral pallidum and globus pallidus to the subthalamic nucleus , 1995, Synapse.

[51]  M. Wong-Riley.  Cytochrome oxidase: an endogenous metabolic marker for neuronal activity , 1989, Trends in Neurosciences.

[52]  J. Hollerman,et al.  Subthalamic nucleus cell firing in the 6-OHDA-treated rat: basal activity and response to haloperidol , 1992, Brain Research.

[53]  A. Jackson,et al.  Nucleus tegmenti pedunculopontinus: Efferent connections with special reference to the basal ganglia, studied in the rat by anterograde and retrograde transport of horseradish peroxidase , 1983, Neuroscience.

[54]  T. Klockgether,et al.  NMDA antagonists potentiate antiparkinsonian actions of L‐dopa in monoamine‐depleted rats , 1990, Annals of neurology.

[55]  C. Wilson,et al.  Projection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[56]  D. Kooy,et al.  The pallido-subthalamic projection in rat: Anatomical and biochemical studies , 1981, Brain Research.

[57]  T. Chase,et al.  Levodopa‐induced dyskinesias improved by a glutamate antagonist in parkinsonia monkeys , 1996 .

[58]  S. T. Kitai,et al.  Cholinergic and noncholinergic tegmental pedunculopontine projection neurons in rats revealed by intracellular labeling , 1996, The Journal of comparative neurology.

[59]  M. Mesulam,et al.  Tetramethyl benzidine for horseradish peroxidase neurohistochemistry: a non-carcinogenic blue reaction product with superior sensitivity for visualizing neural afferents and efferents. , 1978, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[60]  M. Chesselet,et al.  Subthalamic nucleus lesions: widespread effects on changes in gene expression induced by nigrostriatal dopamine depletion in rats , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[61]  O. Hassani,et al.  Electrophysiological study of the excitatory parafascicular projection to the subthalamic nucleus and evidence for ipsi- and contralateral controls , 1995, Neuroscience.

[62]  C. Hammond,et al.  PHARMACOLOGICAL PROPERTIES OF ACETYLCHOLINE‐INDUCED EXCITATION OF SUBTHALAMIC NUCLEUS NEURONES , 1979, British journal of pharmacology.

[63]  K. Lange,et al.  Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-Dopa in models of Parkinson's disease , 1991, Journal of neural transmission. Parkinson's disease and dementia section.

[64]  J. Mitrofanis,et al.  Patterns of connections between zona incerta and brainstem in rats , 1998, The Journal of comparative neurology.

[65]  M. Delong,et al.  Altered Tonic Activity of Neurons in the Globus Pallidus and Subthalamic Nucleus in the Primate MPTP Model of Parkinsonism , 1987 .

[66]  J. Penney,et al.  6-Hydroxydopamine lesions of the nigrostriatal pathway alter the expression of glutamate decarboxylase messenger RNA in rat globus pallidus projection neurons , 1992, Neuroscience.

[67]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[68]  R. J. Allan,et al.  Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson's disease , 1998, Annals of neurology.